Health & Personal Care
HIGH
FDA DRUG
Cipla USA Albuterol Sulfate Inhalation Aerosol Recall Expanded for Stability Variance (2025)
Cipla USA Inc. recalls 20,352 packs of Albuterol Sulfate Inhalation Aerosol after failing stability specifications. The defective lots were distributed nationwide in the United States. The issue involves out of specification results in particle size distribution at the 12-month time point. Patients and healthcare providers should stop use and contact Cipla USA for guidance.
Cipla USA Inc.
Failed Stability